|
ZMYM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.795600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.674500E-02 |
| Normal-vs-Stage2 |
2.171600E-01 |
| Normal-vs-Stage3 |
2.175200E-04 |
| Normal-vs-Stage4 |
3.11570000000039E-06 |
| Stage1-vs-Stage2 |
9.640600E-01 |
| Stage1-vs-Stage3 |
2.030200E-02 |
| Stage1-vs-Stage4 |
1.239570E-03 |
| Stage2-vs-Stage3 |
2.758000E-01 |
| Stage2-vs-Stage4 |
1.382760E-01 |
| Stage3-vs-Stage4 |
4.771400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.079410E-03 |
| Normal-vs-AfricanAmerican |
1.121550E-03 |
| Normal-vs-Asian |
2.757400E-01 |
| Caucasian-vs-AfricanAmerican |
3.475000E-01 |
| Caucasian-vs-Asian |
4.855800E-02 |
| AfricanAmerican-vs-Asian |
1.175770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.626400E-04 |
| Normal-vs-Female |
1.328370E-02 |
| Male-vs-Female |
3.387600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.432400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.390200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.044720E-04 |
| Normal-vs-Age(81-100Yrs) |
3.499000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.884400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.965600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.675200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.568400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.448370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.520200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.578000E-01 |
| Normal-vs-Grade 2 |
1.456560E-01 |
| Normal-vs-Grade 3 |
5.68970000000002E-05 |
| Normal-vs-Grade 4 |
6.79979994533397E-09 |
| Grade 1-vs-Grade 2 |
2.335800E-01 |
| Grade 1-vs-Grade 3 |
1.662070E-02 |
| Grade 1-vs-Grade 4 |
1.043330E-04 |
| Grade 2-vs-Grade 3 |
4.816100E-03 |
| Grade 2-vs-Grade 4 |
2.77429999973045E-07 |
| Grade 3-vs-Grade 4 |
3.079000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.072600E-01 |
| Normal-vs-ccB subtype |
6.13240000000292E-05 |
| ccA subtype-vs-ccB subtype |
6.0210000000005E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.842600E-03 |
| Normal-vs-N1 |
3.403000E-03 |
| N0-vs-N1 |
1.860960E-01 |
|
|
